TD Cowen Upgrades RXO to Hold, Raises Price Target to $30.25

Benzinga Newsdesk www.benzinga.com Positive 90.7%

Neg 0% Neu 0% Pos 90.7%

TD Cowen analyst Jason Seidl upgrades RXO (NYSE:RXO) from Sell to Hold and raises the price target from $17.5 to $30.25.